USA Financial Formulas’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,156
Closed -$173K 455
2026
Q1
$173K Sell
2,156
-7,858
-78% -$648K 0.03% 136
2025
Q4
$854K Sell
10,014
-5,435
-35% -$446K 0.16% 40
2025
Q3
$1.2M Sell
15,449
-1,585
-9% -$124K 0.21% 33
2025
Q2
$1.33M Buy
+17,034
New +$1.27M 0.23% 39
2022
Q1
Sell
-779
Closed -$101K 394
2021
Q4
$101K Buy
779
+758
+3,610% +$88.4K 0.09% 121
2021
Q3
$2K Sell
21
-33
-61% -$3.77K ﹤0.01% 314
2021
Q2
$6K Sell
54
-30
-36% -$2.83K 0.01% 253
2021
Q1
$7K Buy
84
+41
+95% +$3.47K 0.01% 225
2020
Q4
$4K Sell
43
-71
-62% -$5.89K ﹤0.01% 205
2020
Q3
$9K Sell
114
-2
-2% -$156 0.01% 156
2020
Q2
$8K Buy
116
+44
+61% +$3.13K 0.01% 88
2020
Q1
$5K Sell
72
-21,555
-100% -$1.55M ﹤0.01% 158
2019
Q4
$1.68M Buy
21,627
+21,624
+720,800% +$1.69M 0.7% 64
2019
Q3
$0 Buy
+3
New +$211 ﹤0.01% 227
2017
Q4
Sell
-19,332
Closed -$704K 286
2017
Q3
$704K Buy
+19,332
New +$737K 0.17% 117
2016
Q4
Sell
-81,636
Closed -$3.28M 285
2016
Q3
$3.28M Buy
81,636
+2,346
+3% +$88.4K 0.84% 25
2016
Q2
$2.64M Buy
+79,290
New +$2.71M 0.72% 52
2016
Q1
Sell
-156,024
Closed -$4.11M 87
2015
Q4
$4.11M Buy
+156,024
New +$4.05M 1.66% 23
2015
Q2
Sell
-96,786
Closed -$2.3M 233
2015
Q1
$2.3M Buy
96,786
+4,866
+5% +$109K 0.75% 45
2014
Q4
$1.95M Buy
+91,920
New +$1.85M 0.67% 60

Other funds holding EW

USA Financial Formulas's EW Position: Q2 2026 in Review

USA Financial Formulas sold out of Edwards Lifesciences (EW) in Q2 2026, closing a stake of 2,156 shares — an estimated $173K sold.

USA Financial Formulas first reported a position in EW in Q4 2014 and held it in 20 quarters. The position peaked at $4.11M in Q4 2015. 1,325 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • USA Financial Formulas reported no remaining Edwards Lifesciences position as of Q2 2026 after selling out during the quarter.
  • USA Financial Formulas sold 2,156 Edwards Lifesciences shares in Q2 2026, an estimated $173K.
  • USA Financial Formulas first reported a position in Edwards Lifesciences in Q4 2014 and held it in 20 quarters.
  • USA Financial Formulas's Edwards Lifesciences position peaked at $4.11M in Q4 2015.
  • 1,325 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on USA Financial Formulas's 13F filing for Q2 2026, filed 4 Aug 2026.